2022b;12(September):1006576
(4)KO group: TPH1 knockout mice were treated i.p with APAP (TPH1, the rate-limiting enzyme for the synthesis of peripheral serotonin)
AD patients also display additional biomarkers including cerebrovascular pathology and vascular dysfunctions, decreases in cerebral blood flow, cerebrovascular reactivity, and neurovascular coupling, leading to brain deficits in oxygen and nutrient delivery [4,5]
Y.HerfarthK
Kwon DH, Cha HJ, Lee H, Hong SH, Park C, Park SH, Kim GY, Kim S, Kim HS, Hwang HJ, Choi YH
Rather than maxing out a dose, we pull other levers. We might add Cagrilintide , an amylin agonist that synergistically slows gastric emptying, or incorporate MitoQ or SS-31 (Elamipretide) if underlying mitochondrial dysfunction is impairing cellular energy production (ATP)